Denied as “experimental” or “investigational”
Short answer: An “experimental or investigational” denial is a medical judgment, so you can fight it with evidence. Ask the plan for the clinical reasoning and the policy it used, have your doctor answer it with FDA status, medical guidelines and studies, and appeal. If the plan says no again, most plans' denials of this kind can go to an independent external review. If you're in a clinical trial, most plans still have to cover your routine care.
What the denial means
The plan is saying the treatment, drug or device hasn't been proven enough for it to pay. On a claim, you may see reason code 55: “Procedure/treatment/drug is deemed experimental/investigational by the payer.” Notice the last words: by the payer. It's the plan's judgment under its own policy, not a final ruling on your treatment.
Common situations:
- An off-label drug. The drug is FDA-approved, but for a different condition. Doctors generally may prescribe a drug for an unapproved use when they judge it medically appropriate; the FDA just hasn't reviewed that use.
- A newer test, procedure or device the plan's policy hasn't caught up with.
- Care connected to a clinical trial. See the clinical trials section below. You may have more rights than you think.
What the plan has to tell you
For job-based plans, when a denial is based on an experimental-treatment exclusion or medical necessity, the denial notice must either explain the scientific or clinical judgment behind it, applying the plan's terms to your medical situation, or tell you that explanation is available free on request. Ask for it. You can also ask for free copies of all documents, records and other information relevant to your claim, including the medical policy the plan used.
On appeal, a plan deciding whether something is experimental or investigational must consult a health care professional with appropriate training and experience in that field of medicine. Ask that your appeal be reviewed by a specialist in your condition.
How to build the appeal
- Get the plan's policy. Find the exact language it relied on and the evidence standard it uses.
- Ask your doctor for a detailed letter. The strongest letters address the plan's reasoning directly and include:
- The treatment's FDA status, and for a drug, whether your use is on the label.
- Medical society guidelines or standard-of-care references that support it for your condition.
- Published studies, with copies or citations.
- Why standard treatments have failed, aren't appropriate, or carry more risk for you.
- For an off-label drug, check the compendia. Medicare contractors decide many off-label drug claims by looking at major drug compendia and medical literature. For example, one Medicare contractor's policy accepts uses rated Category 1 or 2A in the NCCN Drugs and Biologics Compendium. Your doctor can cite these listings for private plans too.
- File on time. Job-based and Marketplace plans generally give you at least 180 days to appeal. Check your deadline. If treatment can't wait, ask for an expedited appeal.
What to say in your appeal letter
Keep it short and specific. A simple structure:
- Identify the claim: your name, member ID, claim or reference number, the service, and the date of the denial.
- Quote the reason: copy the plan's exact words, including any policy name or number it cited.
- Answer it: for example, “This drug is FDA-approved and is listed in [compendium] for my condition,” or “National guidelines from [medical society] recommend this treatment for patients like me, as my doctor's letter explains.”
- Ask for the right reviewer: request that a physician in the same specialty, who wasn't involved in the first decision, review the appeal.
- Ask for the reasoning: if the denial didn't explain the scientific or clinical judgment, ask for it in writing.
- List your enclosures and ask the plan to reverse the denial.
Send it to the appeals address on the denial, and keep a copy and proof of the date you sent it.
If the plan says no again: external review
Under federal rules, external review covers denials that involve medical judgment, and the rule specifically lists a plan's decision that a treatment is experimental or investigational. That means an independent reviewer, not your insurer, can make the final call. You generally have 4 months after the final internal denial to ask. If the reviewer overturns the denial, the insurer has to accept the decision. How external review works.
State external review programs must have procedures for experimental and investigational denials. Some states have their own extra steps. For example:
- New York allows external appeals of experimental or investigational denials, and asks for a form from your physician. The attestation includes a statement that standard health services or procedures have been ineffective or would be medically inappropriate.
- California's Independent Medical Review program reviews denials of treatment as medically unnecessary or experimental/investigational.
Find your state's external review program.
Clinical trials: what most plans must cover
Under the Affordable Care Act, non-grandfathered job-based and individual plans can't deny you the chance to take part in an approved clinical trial for cancer or another life-threatening disease or condition, can't deny or limit coverage of your routine patient costs in the trial, and can't discriminate against you for taking part.
- Routine costs are items and services the plan would normally cover.
- Not included: the investigational item, device or service itself; items and services provided only for the trial's data collection and analysis; and services clearly inconsistent with widely accepted standards of care.
- You qualify if you're eligible for the trial under its protocol and either an in-network provider has concluded the trial is appropriate for you, or you provide medical and scientific information showing it is. A plan can require you to use an in-network trial provider if one will accept you.
So if the plan denied a routine scan, doctor visit or hospital stay just because you're in a trial, that denial may conflict with federal law. Say so in your appeal.
Medicare covers the routine costs of qualifying clinical trials, such as care you'd get even without the trial. It doesn't cover the investigational item itself unless Medicare otherwise covers it, items used only for data collection, or items the research sponsor usually provides free. You may pay 20% of the Medicare-approved amount, depending on the treatment.
A note on Medicare and experimental denials
Original Medicare covers services that meet accepted standards of medical practice to diagnose or treat your condition. If Medicare or a Medicare Advantage plan denies something as unproven, use Medicare's appeal process: Original Medicare or Medicare Advantage.
Your next question
Denied as “not a covered benefit”A 'not covered' (CO-96) denial is a fight over the plan's own words. How to use your plan documents, and what…Denied as “not medically necessary”A 'not medically necessary' (CO-50) denial is a judgment call, and those get reversed. The key: a doctor's…How to request an independent external reviewAfter your insurer's final no, an independent reviewer can overturn it, and the insurer must follow the… Check your appeal deadlinePick your plan type and the date on your letter. Free, and nothing is sent anywhere.Common questions
What does denial code 55 mean?
Claim adjustment reason code 55 means the procedure, treatment or drug is deemed experimental or investigational by the payer. It's the plan's judgment under its own policy, and you can appeal it.
Can an experimental denial go to external review?
Yes for most job-based and individual plans. Federal rules list a plan's determination that a treatment is experimental or investigational as a medical-judgment denial eligible for independent external review.
Will my insurance pay for care during a clinical trial?
Most non-grandfathered plans must cover routine patient costs for people in approved clinical trials for cancer or another life-threatening condition. They don't have to pay for the investigational item itself or for data-collection services.
Let the app write it for you
Snap a photo of your denial letter. Appeal My Denial tells you why you were denied, your exact deadline, and drafts the appeal letter, plus the note for your doctor.
Coming soon to the App StoreSources
- X12: Claim Adjustment Reason Codes
- FDA: Understanding Unapproved Use of Approved Drugs “Off Label”
- 29 CFR 2560.503-1 (ERISA claims procedure, eCFR)
- CMS Medicare Coverage Database: LCD L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
- 45 CFR 147.136 (internal claims and appeals and external review, eCFR)
- HealthCare.gov: External review
- New York Department of Financial Services: External Appeal
- California Department of Insurance: Independent Medical Review Program
- 42 U.S.C. 300gg-8 (coverage for individuals in approved clinical trials)
- DOL: FAQs about Affordable Care Act Implementation (Part XV) — clinical trials
- CMS: National Coverage Determination 310.1, Routine Costs in Clinical Trials
- Medicare.gov: Clinical research study coverage
- Medicare.gov: What Part B covers